BidaskClub Lowers CryoPort (NASDAQ:CYRX) to Hold

CryoPort (NASDAQ:CYRX) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, BidAskClub reports.

CYRX opened at $18.15 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 11.52 and a current ratio of 11.57. CryoPort has a 1 year low of $8.28 and a 1 year high of $18.99. The company has a market capitalization of $556.77 million, a P/E ratio of -58.55 and a beta of 0.85.

CryoPort (NASDAQ:CYRX) last released its earnings results on Thursday, May 2nd. The consumer goods maker reported ($0.08) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.08). CryoPort had a negative net margin of 41.61% and a negative return on equity of 28.30%. The business had revenue of $6.65 million for the quarter, compared to analysts’ expectations of $6.56 million. During the same period last year, the company earned ($0.10) earnings per share. The company’s quarterly revenue was up 65.4% on a year-over-year basis. As a group, equities research analysts anticipate that CryoPort will post -0.29 EPS for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in CYRX. FMR LLC acquired a new stake in shares of CryoPort in the fourth quarter worth approximately $4,556,000. Pier Capital LLC boosted its position in shares of CryoPort by 48.6% in the first quarter. Pier Capital LLC now owns 505,334 shares of the consumer goods maker’s stock worth $6,529,000 after acquiring an additional 165,229 shares during the last quarter. Roubaix Capital LLC acquired a new stake in shares of CryoPort in the first quarter worth approximately $1,679,000. JPMorgan Chase & Co. boosted its position in shares of CryoPort by 35.9% in the third quarter. JPMorgan Chase & Co. now owns 216,523 shares of the consumer goods maker’s stock worth $2,774,000 after acquiring an additional 57,154 shares during the last quarter. Finally, Premier Asset Management LLC boosted its position in shares of CryoPort by 262.3% in the fourth quarter. Premier Asset Management LLC now owns 69,060 shares of the consumer goods maker’s stock worth $762,000 after acquiring an additional 50,000 shares during the last quarter. 53.20% of the stock is currently owned by institutional investors and hedge funds.

CryoPort Company Profile

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Further Reading: How Do You Calculate Return on Investment (ROI)?

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.